Endometrial cancer stem cells

A new target for cancer therapy

Research output: Contribution to journalReview article

14 Citations (Scopus)

Abstract

Adult stem cells have recently been identified in several types of mature tissue and it has also been suggested that stem-like cells exist in cancerous tissues. In this regard, stem-like cell subpopulations, referred to as side-population (SP) cells, have been identified in several tissue and tumor types, based on their ability to remove intracellular Hoechst 33342, a fluorescent dye. We have isolated and characterized SP cells from normal human endometrium and an endometrial cancer cell line. Endometrial SP cells can function as progenitor cells. Endometrial cancer SP cells possess the following characteristics: i) reduced expression levels of differentiation markers, ii) long-term repopulating properties, iii) self-renewal capacity, iv) enhanced migration and podia formation, v) enhanced tumorigenicity, and vi) bi-potential development (tumor cells and stroma-like cells), suggesting that they have cancer stem-like cell features. Recently, we demonstrated that sodium butyrate, a histone deacetylase (HDAC) inhibitor, inhibited the self-renewal capacity of endometrial cancer SP cells by inducing a DNA damage response. Here, we review recent articles that show the presence of stem cells in normal endometrium and endometrial cancer and introduce the results of our own recent studies.

Original languageEnglish
Pages (from-to)2283-2293
Number of pages11
JournalAnticancer Research
Volume32
Issue number6
Publication statusPublished - Jun 2012
Externally publishedYes

Fingerprint

Side-Population Cells
Neoplastic Stem Cells
Endometrial Neoplasms
Stem Cells
Neoplasms
Therapeutics
Adult Stem Cells
Histone Deacetylase Inhibitors
Butyric Acid
Differentiation Antigens
Fluorescent Dyes
DNA Damage
Cell Line

All Science Journal Classification (ASJC) codes

  • Cancer Research
  • Oncology

Cite this

Endometrial cancer stem cells : A new target for cancer therapy. / Kato, Kiyoko.

In: Anticancer Research, Vol. 32, No. 6, 06.2012, p. 2283-2293.

Research output: Contribution to journalReview article

@article{6298961ac555479288e9b178e4d2bedb,
title = "Endometrial cancer stem cells: A new target for cancer therapy",
abstract = "Adult stem cells have recently been identified in several types of mature tissue and it has also been suggested that stem-like cells exist in cancerous tissues. In this regard, stem-like cell subpopulations, referred to as side-population (SP) cells, have been identified in several tissue and tumor types, based on their ability to remove intracellular Hoechst 33342, a fluorescent dye. We have isolated and characterized SP cells from normal human endometrium and an endometrial cancer cell line. Endometrial SP cells can function as progenitor cells. Endometrial cancer SP cells possess the following characteristics: i) reduced expression levels of differentiation markers, ii) long-term repopulating properties, iii) self-renewal capacity, iv) enhanced migration and podia formation, v) enhanced tumorigenicity, and vi) bi-potential development (tumor cells and stroma-like cells), suggesting that they have cancer stem-like cell features. Recently, we demonstrated that sodium butyrate, a histone deacetylase (HDAC) inhibitor, inhibited the self-renewal capacity of endometrial cancer SP cells by inducing a DNA damage response. Here, we review recent articles that show the presence of stem cells in normal endometrium and endometrial cancer and introduce the results of our own recent studies.",
author = "Kiyoko Kato",
year = "2012",
month = "6",
language = "English",
volume = "32",
pages = "2283--2293",
journal = "Anticancer Research",
issn = "0250-7005",
publisher = "International Institute of Anticancer Research",
number = "6",

}

TY - JOUR

T1 - Endometrial cancer stem cells

T2 - A new target for cancer therapy

AU - Kato, Kiyoko

PY - 2012/6

Y1 - 2012/6

N2 - Adult stem cells have recently been identified in several types of mature tissue and it has also been suggested that stem-like cells exist in cancerous tissues. In this regard, stem-like cell subpopulations, referred to as side-population (SP) cells, have been identified in several tissue and tumor types, based on their ability to remove intracellular Hoechst 33342, a fluorescent dye. We have isolated and characterized SP cells from normal human endometrium and an endometrial cancer cell line. Endometrial SP cells can function as progenitor cells. Endometrial cancer SP cells possess the following characteristics: i) reduced expression levels of differentiation markers, ii) long-term repopulating properties, iii) self-renewal capacity, iv) enhanced migration and podia formation, v) enhanced tumorigenicity, and vi) bi-potential development (tumor cells and stroma-like cells), suggesting that they have cancer stem-like cell features. Recently, we demonstrated that sodium butyrate, a histone deacetylase (HDAC) inhibitor, inhibited the self-renewal capacity of endometrial cancer SP cells by inducing a DNA damage response. Here, we review recent articles that show the presence of stem cells in normal endometrium and endometrial cancer and introduce the results of our own recent studies.

AB - Adult stem cells have recently been identified in several types of mature tissue and it has also been suggested that stem-like cells exist in cancerous tissues. In this regard, stem-like cell subpopulations, referred to as side-population (SP) cells, have been identified in several tissue and tumor types, based on their ability to remove intracellular Hoechst 33342, a fluorescent dye. We have isolated and characterized SP cells from normal human endometrium and an endometrial cancer cell line. Endometrial SP cells can function as progenitor cells. Endometrial cancer SP cells possess the following characteristics: i) reduced expression levels of differentiation markers, ii) long-term repopulating properties, iii) self-renewal capacity, iv) enhanced migration and podia formation, v) enhanced tumorigenicity, and vi) bi-potential development (tumor cells and stroma-like cells), suggesting that they have cancer stem-like cell features. Recently, we demonstrated that sodium butyrate, a histone deacetylase (HDAC) inhibitor, inhibited the self-renewal capacity of endometrial cancer SP cells by inducing a DNA damage response. Here, we review recent articles that show the presence of stem cells in normal endometrium and endometrial cancer and introduce the results of our own recent studies.

UR - http://www.scopus.com/inward/record.url?scp=84864564755&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864564755&partnerID=8YFLogxK

M3 - Review article

VL - 32

SP - 2283

EP - 2293

JO - Anticancer Research

JF - Anticancer Research

SN - 0250-7005

IS - 6

ER -